368 related articles for article (PubMed ID: 16339517)
1. Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.
Karimi M; Cao TM; Baker JA; Verneris MR; Soares L; Negrin RS
J Immunol; 2005 Dec; 175(12):7819-28. PubMed ID: 16339517
[TBL] [Abstract][Full Text] [Related]
2. Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells.
Verneris MR; Karimi M; Baker J; Jayaswal A; Negrin RS
Blood; 2004 Apr; 103(8):3065-72. PubMed ID: 15070686
[TBL] [Abstract][Full Text] [Related]
3. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.
Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE
J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177
[TBL] [Abstract][Full Text] [Related]
4. T cells gene-engineered with DAP12 mediate effector function in an NKG2D-dependent and major histocompatibility complex-independent manner.
Teng MW; Kershaw MH; Hayakawa Y; Cerutti L; Jane SM; Darcy PK; Smyth MJ
J Biol Chem; 2005 Nov; 280(46):38235-41. PubMed ID: 16169855
[TBL] [Abstract][Full Text] [Related]
5. NKG2D splice variants: a reexamination of adaptor molecule associations.
Rabinovich B; Li J; Wolfson M; Lawrence W; Beers C; Chalupny J; Hurren R; Greenfield B; Miller R; Cosman D
Immunogenetics; 2006 Apr; 58(2-3):81-8. PubMed ID: 16470377
[TBL] [Abstract][Full Text] [Related]
6. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.
Gilfillan S; Ho EL; Cella M; Yokoyama WM; Colonna M
Nat Immunol; 2002 Dec; 3(12):1150-5. PubMed ID: 12426564
[TBL] [Abstract][Full Text] [Related]
7. Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics.
Graham DB; Cella M; Giurisato E; Fujikawa K; Miletic AV; Kloeppel T; Brim K; Takai T; Shaw AS; Colonna M; Swat W
J Immunol; 2006 Aug; 177(4):2349-55. PubMed ID: 16887996
[TBL] [Abstract][Full Text] [Related]
8. Cloning, sequencing, and cell surface expression pattern of bovine immunoreceptor NKG2D and adaptor molecules DAP10 and DAP12.
Fikri Y; Nyabenda J; Content J; Huygen K
Immunogenetics; 2007 Aug; 59(8):653-9. PubMed ID: 17530242
[TBL] [Abstract][Full Text] [Related]
9. NKG2D ligation without T cell receptor engagement triggers both cytotoxicity and cytokine production in dendritic epidermal T cells.
Nitahara A; Shimura H; Ito A; Tomiyama K; Ito M; Kawai K
J Invest Dermatol; 2006 May; 126(5):1052-8. PubMed ID: 16484989
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.
André P; Castriconi R; Espéli M; Anfossi N; Juarez T; Hue S; Conway H; Romagné F; Dondero A; Nanni M; Caillat-Zucman S; Raulet DH; Bottino C; Vivier E; Moretta A; Paul P
Eur J Immunol; 2004 Apr; 34(4):961-71. PubMed ID: 15048706
[TBL] [Abstract][Full Text] [Related]
11. A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia.
Chen X; Bai F; Sokol L; Zhou J; Ren A; Painter JS; Liu J; Sallman DA; Chen YA; Yoder JA; Djeu JY; Loughran TP; Epling-Burnette PK; Wei S
Blood; 2009 Apr; 113(14):3226-34. PubMed ID: 19075187
[TBL] [Abstract][Full Text] [Related]
12. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases.
Zompi S; Hamerman JA; Ogasawara K; Schweighoffer E; Tybulewicz VL; Di Santo JP; Lanier LL; Colucci F
Nat Immunol; 2003 Jun; 4(6):565-72. PubMed ID: 12740576
[TBL] [Abstract][Full Text] [Related]
13. Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways.
Coudert JD; Scarpellino L; Gros F; Vivier E; Held W
Blood; 2008 Apr; 111(7):3571-8. PubMed ID: 18198346
[TBL] [Abstract][Full Text] [Related]
14. Activation of V gamma 9V delta 2 T cells by NKG2D.
Rincon-Orozco B; Kunzmann V; Wrobel P; Kabelitz D; Steinle A; Herrmann T
J Immunol; 2005 Aug; 175(4):2144-51. PubMed ID: 16081780
[TBL] [Abstract][Full Text] [Related]
15. An activating immunoreceptor complex formed by NKG2D and DAP10.
Wu J; Song Y; Bakker AB; Bauer S; Spies T; Lanier LL; Phillips JH
Science; 1999 Jul; 285(5428):730-2. PubMed ID: 10426994
[TBL] [Abstract][Full Text] [Related]
16. DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapy.
Töpfer K; Cartellieri M; Michen S; Wiedemuth R; Müller N; Lindemann D; Bachmann M; Füssel M; Schackert G; Temme A
J Immunol; 2015 Apr; 194(7):3201-12. PubMed ID: 25740942
[TBL] [Abstract][Full Text] [Related]
17. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells.
Wu J; Cherwinski H; Spies T; Phillips JH; Lanier LL
J Exp Med; 2000 Oct; 192(7):1059-68. PubMed ID: 11015446
[TBL] [Abstract][Full Text] [Related]
18. Regulation of human DAP10 gene expression in NK and T cells by Ap-1 transcription factors.
Marusina AI; Burgess SJ; Pathmanathan I; Borrego F; Coligan JE
J Immunol; 2008 Jan; 180(1):409-17. PubMed ID: 18097042
[TBL] [Abstract][Full Text] [Related]
19. Sestrins induce natural killer function in senescent-like CD8
Pereira BI; De Maeyer RPH; Covre LP; Nehar-Belaid D; Lanna A; Ward S; Marches R; Chambers ES; Gomes DCO; Riddell NE; Maini MK; Teixeira VH; Janes SM; Gilroy DW; Larbi A; Mabbott NA; Ucar D; Kuchel GA; Henson SM; Strid J; Lee JH; Banchereau J; Akbar AN
Nat Immunol; 2020 Jun; 21(6):684-694. PubMed ID: 32231301
[TBL] [Abstract][Full Text] [Related]
20. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
Wiemann K; Mittrücker HW; Feger U; Welte SA; Yokoyama WM; Spies T; Rammensee HG; Steinle A
J Immunol; 2005 Jul; 175(2):720-9. PubMed ID: 16002667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
